Dorayshield announced that its first batch of five tungsten alloy unit dose pigs has arrived in Australia and has been delivered to a local nuclear medicine center. This order marks the company's first entry into the Oceania market for its high-density tungsten shielding products, laying the foundation for the subsequent expansion of its network of public nuclear pharmacies in Australia.
The exported syringe unit dose pigs are made of 93W-Ni-Fe alloy, with a density of 17.8 g/cm³ and a weight of 3.6 kg per unit. Their inner cavity precisely fits a standard 10 mL vial, and their 3 mm wall thickness reduces the surface dose rate of 1 GBq 99mTc to <5 μSv/h, meeting the requirements of Australia's radiation safety regulations, ARPANSA. The customer, a newly established PET/CT facility in Melbourne, selected Dorayshield after comparing quotes from three European and American suppliers. The selection was based on the company's 10-day delivery from its Chinese factory, a 15% discount to comparable European-made shields, and the inclusion of an ISO Declaration of Conformity and a Material Traceability Report.
This export is a culmination of Dorayshield's committed efforts in tungsten alloy shielding for unsurpassed market penetration. Recently, the company has been focusing on product line R&D, as well as quality improvement, by forming a dedicated technical team to streamline the design and production of shield covers. The team simultaneously addresses effective protection and increases the product's portability and multifunctionality. The company has also designed a comprehensive foreign trade service. In an attempt to serve diverse global markets, they provide order coordination, shipping, and after-sales logistics integrated support. The company has strong customer recognition in many countries. Entering the Australian market is the gateway to our expanding reach to the entire region of Oceania.
For Dorayshield, this export to Australia is more than just fulfilling an order; it also grants access to a new market. Moving ahead, the company plans to use this partnership to keep track of the demand within the Australian and Oceania regions, refine its offerings, and bolster its overseas market development. This will enhance the international market presence of premium tungsten alloy protective products, assist the company in the more positive development of its foreign trade, and strengthen the global radiation protective market.
